Sectra ABCHIX:SECTBS 98 Net Margin % is 15.24% as of Apr. 2026, which is 2% below its 10-year median of 15.60. GuruFocus rates CHIX:SECTBS with a GF Score™ of 98/100 and a GF Value™ of kr307.25 (Modestly Undervalued). Among 817 Medical Devices & Instruments companies, Sectra AB ranks better than 83.84% on this metric.
Net margin is calculated as Net Income divided by its Revenue. Sectra AB's Net Income for the
three
months ended in Apr. 2026 was kr157 Mil. Sectra AB's Revenue for the
three
months ended in Apr. 2026 was kr1,033 Mil. Therefore, Sectra AB's net margin for the quarter that ended in Apr. 2026 was 15.24%.
The historical rank and industry rank for Sectra AB's Net Margin % or its related term are showing as below:
CHIX:SECTBs'
s Net Margin % Range Over the Past 10 Years
Min: 13.37 Med: 15.6 Max: 17.39
Current: 15.92
CHIX:SECTBs's Net Margin % is ranked better than 83.84% of 817
companies
in the Medical Devices & Instruments industry
Industry Median: 2.09
vs CHIX:SECTBs: 15.92
Sectra AB (CHIX:SECTBs) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
Sectra AB Net Margin % Related Terms
Sectra AB Net Margin % Historical Data
* Premium members only.
The historical data trend for Sectra AB's Net Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CHIX:SECTBS vs ABT, SYK, MDT: Net Margin % Comparison
For the Medical Devices subindustry, Sectra AB's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sectra AB Net Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Sectra AB's Net Margin % distribution charts can be found below:
* The bar in red indicates where Sectra AB's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sectra AB (CHIX:SECTBS) has a Net Margin % of 15.24% as of Apr. 2026. Net margin is the ratio of total net income to net sales. View historical data on Sectra AB and its competitors. This is near median its historical median of 15.60. Over the past decade, Sectra AB's Net Margin % has ranged from 13.37 to 17.39. According to the industry distribution chart, Sectra AB ranks #132 out of 817 companies in the Medical Devices & Instruments industry, placing it in the top 16.2%.
Is Sectra AB's Net Margin % too high?
Sectra AB's current Net Margin % of 15.24% is near median its 10-year median of 15.60. Over the past 10 years, this metric has ranged from a low of 13.37 to a high of 17.39. The Medical Devices & Instruments industry median Net Margin % is 2.09. Sectra AB's value of 15.24% is 629.2% above this industry median. Based on the distribution chart, Sectra AB ranks #132 out of 817 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Sectra AB has a GF Score™ of 98/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Sectra AB's Net Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Sectra AB ranks #132 out of 817 companies for Net Margin %. This places Sectra AB in the top 16% of its industry — outperforming the majority of peers. The industry median Net Margin % is 2.09. Sectra AB's value of 15.24% is 629.2% above this benchmark. Historically, Sectra AB's own Net Margin % has ranged from 13.37 to 17.39 over the past decade. While the company's 10-year median is 15.60 vs. the industry median of 2.09, Sectra AB has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Medical Devices & Instruments company?
The median Net Margin % among Medical Devices & Instruments companies is 2.09, based on 817 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sectra AB's current Net Margin % of 15.24% is 629.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Sectra AB and its competitors. For the Medical Devices & Instruments industry, the median Net Margin % is 2.09 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sectra AB's current Net Margin % is 15.24%, which is near median its own 10-year median of 15.60. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sectra AB stock overvalued right now?
Based on GuruFocus' analysis, Sectra AB (CHIX:SECTBS) is currently considered Modestly Undervalued. The stock's GF Value™ is kr307.25, compared to a current price of kr277.30 — trading 9.7% below its estimated fair value. The current Net Margin % is 15.24%, which is near median its 10-year median of 15.60 and 629.2% above the Medical Devices & Instruments industry median of 2.09. Sectra AB's overall GF Score™ is 98/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Sectra AB (CHIX:SECTBS), the current Net Margin % is 15.24% as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sectra AB (CHIX:SECTBS) Overvalued in 2026?
Based on GuruFocus' analysis, Sectra AB stock appears to be undervalued.
The current stock price of kr277.30 is trading 9.7% below its estimated GF Value™ of kr307.25.
GuruFocus considers Sectra AB to be Modestly Undervalued.
Key valuation signals for CHIX:SECTBS:
Net Margin %: 15.24% (near median its 10-year median of 15.60)
GF Value™: kr307.25 vs. price of kr277.30 (9.7% below fair value)
Industry Position: 629.2% above the Medical Devices & Instruments median (#132 of 817)
No single metric tells the full story. See the CHIX:SECTBS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sectra AB develops IT solutions and services for storing, viewing, and working with medical images. The operating business segments are Imaging IT Solutions, Secure Communications, Business Innovation, and Other Operations. It generates maximum revenue from the Imaging IT Solutions segment. The company also offers maintenance in the form of support, system monitoring, and consulting services related to integration, system design, data migration, and business development. Geographically, it derives a majority of its revenue from the United States, followed by Sweden, the United Kingdom, the Netherlands, the Rest of Europe, and the Rest of the world.
98GF Score
Get the complete analysis for CHIX:SECTBS
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CHIX:SECTBS has been successfully added to your 
